Xanthan gum
Based on 1 Customer Validation
Xanthan gum interacts with gelatin (HY-Y1365) via hydrogen bonds, thereby increasing the viscosity and stability of the hydrogel while promoting cell growth and creating a microenvironment conducive to cell differentiation[1][2]. Xanthan gum induces pro-inflammatory responses by increasing the levels of TNF-α, IL-6, and IL-10. Xanthan gum can be used for inflammation and immunology research.
For research use only. We do not sell to patients.
- Purity : 98.0%
- CAS No.: 11138-66-2
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Description
In Vitro
Xanthan gum (3 %, 0-28 days) exhibits good biocompatibility, as evidenced by increasing metabolic activity of hMSCs without compromising cell viability[1].
Xanthan gum (1.2 %, 2 days) in 2.5Gel3 and 3Gel4 hydrogels demonstrates a moisture retention of ~95% after hydration at 37°C[2].
Xanthan gum (1.2 %, 0-24 h) in 2.5Gel3 and 3Gel4 hydrogels shows a swelling ratio that peaks at 3 h and stabilizes until 24 h, and exhibits minimal morphological changes after 1-3 h of crosslinking with 0.3 v/v% glutaraldehyde[2].
Xanthan gum (1.2 %, 0-10 days) in 2.5Gel3 and 3Gel4 hydrogels displays a hydrolysis profile that peaks at 10 days, and respective porosities of ~65% and ~30%[2].
Xanthan gum (1.2 %, 0-14 days) in 2.5Gel3 and 3Gel4 hydrogels supports the growth of co-cultured human skin fibroblasts and keratinocytes, as evidenced by a significant increase in cell numbers from day 1 to day 7, with a further increase observed by day 14[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:hMSCs
-
Concentration:3%
-
Incubation Time:Day 0, Day 1, Day 4, Day 7
-
Result:Showed decreased viability at Day 1, while the overall viability after Day 4 of the hydrogel system is over 90%, demonstrating cytocompatibility of the proposed hydrogel with gum.
-
Cell Line:hMSCs
-
Concentration:3%
-
Incubation Time:Day 0, Day 3, Day 7, Day 14, Day 21, Day 28
-
Result:Showed a significant increase in cell metabolic activity from Day 0 to Day 3, which stabilized over the longer term of more than one week.
In Vivo
Xanthan gum (5%, p.o., continuous feeding) promotes expansion of R.UCG13 and B. intestinalis in the gut microbiome of Swiss Webster mice[4].
Xanthan gum (5%, p.o., form day0 to day23) maintains the mice microbiota during antibiotic treatment, leading to limited to no C. difficile colonization[5].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male Wistar rats (5 weeks old, consumed xanthan gum for 8 weeks) subcutaneously injected with Walker 256 tumor cells[3]
-
Dosage:185 mg/100 g mixed in diet
-
Administration:p.o., daily from 5 to 15 weeks of age
-
Result:Increased IL-6, TNF-α, and IL-10 in retroperitoneal adipose tissue.
Did not affect the development of Walker 256 tumors in rats.
Showed no significant changes in body weight, total dietary intake, tissue weights or fat and protein contents of the carcasses in rats.
-
Animal Model:Female Swiss Webster mice[4]
-
Dosage:5%
-
Administration:p.o., continuous feeding
-
Result:Promoted the expansion of the primary degrader R.UCG13.
Supported the colonization of an introduced Bacteroides intestinalis strain, enabling it to outcompete the endogenous strain.
Enabled the expansion of B. intestinalis via oligosaccharides released by R.UCG13.
Removal from the diet reduced R.UCG13 abundance, confirming its role in sustaining this bacterium.
-
Animal Model:C57BL/6 mice (6-8 weeks olds) infected with C. difficile[5]
-
Dosage:5%
-
Administration:p.o., form day 0 to day 23
-
Result:Maintained both diversity and overall abundance of microbes in the gut during Cefoperazone (HY-B0210) administration.
Resulted in a shift in bacterial metabolism marked by significantly higher butyrate and propionate concentrations in mice compared to those on standard chow.
Disrupted 48 of the 112 OTUs that were negatively correlated with Cefoperazone treatment in the standard chow group.
Partially protected the microbiota from the effects of Cefoperazone, and preserved colonization resistance to C. difficile.
Led to a significant reduction in C. difficile colonization levels by day15, compared to standard chow, in the antibiotic cocktail model (Kanamycin (HY-16566), Gentamicin (HY-A0276A), Colistin (HY-A0089), Metronidazole (HY-B0318), and Vancomycin (HY-B0671)).
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 11138-66-2
-
Appearance Solid
-
Color White to light yellow
-
SMILES
CC([R4])(C(O)=O)[R6].OC[C@@H]1[C@@H](COC)[C@H](O)[C@@H](O)[C@H](OOC[C@@H]2[C@@H](CO)O[C@@H](CC)[C@H](O)[C@@H]2COC[C@H]3[C@H](COC[C@H]4[C@H](O)[C@@H](O)[C@H](COC[C@H]5[C@H](O)[C@@H](O)[C@H](O[R])[C@@H](CO[R])O5)[C@@H](C(O)=O)O4)[C@@H](O)[C@H](O)[C@@H](COC(C)=O)O3)C1.[n]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
In Vitro:
H2O : 2.5 mg/mL (Need ultrasonic)
Protocols
-
3D Hydrogel Synthetic Scaffold Culture
3D hydrogel synthetic scaffold culture embeds cells, spheroids, organoids, or tissue fragments inside a hydrated crosslinked polymer network so that cells receive matrix and cell-cell cues in three dimensions rather than from a flat plastic surface. A literature-supported model protocol is PEG-4MAL hydrogel culture, in which four-arm maleimide-terminated PEG is functionalized with cysteine-containing adhesive peptides such as RGD and crosslinked with protease-degradable peptides such as GPQ-W; this creates a defined, modular scaffold that supports human organoid generation and culture. The readouts are scaffold-supported growth, morphology, lumen formation, budding, viability, proliferation, lineage-marker expression, and matrix-dependent expansion or differentiation; reported assays include transmitted-light imaging, immunofluorescence, in situ hybridization, qRT-PCR, and rheological characterization.
-
Protocol for Cell Counting and Cell Density Analysis
Cell counting and cell-density analysis estimate the number of cells in a known volume or field area. Manual hemocytometer counting uses a chamber of defined geometry to convert counted cells into cells/mL, while automated counters and image-analysis workflows detect cell objects from optical, brightfield, fluorescence, impedance, or digital-image features. Trypan blue viability counting is based on dye exclusion: viable cells with intact membranes exclude dye, while non-viable cells with compromised membranes stain blue. The readout is total cell density, viable-cell density, dead-cell density, and percent viability. Cell density can also be estimated from microscopy images by counting objects per image area, from flow cytometry using calibrated volume or reference particles, or from in situ microscopy in bioreactors after calibration against reference methods such as hemocytometer or flow cytometry.
-
Somatic Cell Culture
A method of simulating the in vivo environment in vitro to maintain the cell growth, differentation and main functions.
-
CCK-8/WST-8 Cell Proliferation Assay
The CCK-8/WST-8 assay is based on the reduction of the water-soluble tetrazolium salt WST-8 to a water-soluble formazan product by cellular dehydrogenases in metabolically active cells, where the generated formazan amount is proportional to the number of living cells and is quantified by measuring absorbance in the visible range, providing a colorimetric readout for cell viability and proliferation assessment. This class of tetrazolium-based assays improves upon earlier MTT-based systems by producing a water-soluble formazan, eliminating the need for organic solubilization steps and enabling direct spectrophotometric measurement in culture medium.
-
Cell Counting-Based Growth Curve Assay
Cell counting-based growth curve assays quantify cell proliferation by directly measuring changes in viable cell number over time using manual or automated counting methods such as hemocytometer-based counting or instrument-assisted cell enumeration, enabling construction of growth curves that reflect population expansion dynamics in response to culture conditions. A widely used approach is trypan blue exclusion with hemocytometer counting, where membrane-compromised (non-viable) cells take up the dye, allowing discrimination between viable and non-viable cells while simultaneously enabling total cell number quantification. Repeated sampling across time points allows estimation of proliferation rate, growth phases, and comparative growth kinetics between experimental conditions.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
MTT Cell Proliferation Assay
The MTT assay is a colorimetric endpoint assay for estimating viable cell number, cell growth, cytotoxicity, or cell activation in cultured mammalian cells. Living cells reduce the yellow tetrazolium salt MTT into purple/blue formazan, while dead cells do not generate the same signal; the resulting color can be quantified with a multiwell spectrophotometer. MTT reduction is commonly interpreted as a readout of metabolic activity that often correlates with viable cell number, but it should not be treated as a direct cell-counting method unless the assay is optimized for the cell type and experimental condition. Studies show that MTT reduction can involve mitochondrial and non-mitochondrial reducing systems, and formazan may accumulate in intracellular lipid droplets rather than simply marking mitochondria.
-
iPSC cell differentiation
Induced pluripotent stem cells (iPSCs) are a type of cell that has similar properties to embryonic stem cells through somatic cell reprogramming.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
-
Data Sheet (294 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Li J, et al. Development and systematic characterization of GelMA/alginate/PEGDMA/xanthan gum hydrogel bioink system for extrusion bioprinting. Biomaterials. 2023;293:121969. [Content Brief]
[2]. Piola B, et al. 3D Bioprinting of Gelatin-Xanthan Gum Composite Hydrogels for Growth of Human Skin Cells. Int J Mol Sci. 2022;23(1):539. Published 2022 Jan 4. [Content Brief]
[3]. Silva Rischiteli AB, et al. A diet including xanthan gum triggers a pro-inflammatory response in Wistar rats inoculated with Walker 256 cells. PLoS One. 2019;14(6):e0218567. Published 2019 Jun 18. [Content Brief]
[4]. Ostrowski MP, et al. Mechanistic insights into consumption of the food additive xanthan gum by the human gut microbiota. Nat Microbiol. 2022;7(4):556-569. [Content Brief]
[5]. Schnizlein MK, et al. Dietary Xanthan Gum Alters Antibiotic Efficacy against the Murine Gut Microbiota and Attenuates Clostridioides difficile Colonization. mSphere. 2020;5(1):e00708-19. Published 2020 Jan 8. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Xanthan gum
- 11138-66-2
- Environmental Pollutants
- Biochemical Assay Reagents
- pro-inflammatory factors
- cytokines
- thickening agent
- polysaccharide
- human microbiomes
- interface
- xanthan gum
- diet
- gut microbiota
- dietary fiber
- hydrocolloid
- IL-6
- food chain
- coconut protein
- interaction
- Ruminococcaceae
- Bacteroides intestinalis
- emulsion stabilization
- IL-10
- drug delivery
- stabilizer
- TNF-α
- rheological properties
- adipose tissue
- Walker 256 tumor cells
- tumor development
- Inhibitor
- inhibitor
- inhibit